302 related articles for article (PubMed ID: 33041091)
21. [Effect of ω-3 polyunsaturated fatty acids on predictors of sudden cardiac death in patients with ischemic heart disease and ventricular rhythm disturbances].
Gavva EM; Tsaregorodtsev DA; Mamedov IS; Sulimov VA
Kardiologiia; 2012; 52(7):14-21. PubMed ID: 22839709
[TBL] [Abstract][Full Text] [Related]
22. Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting.
Schmöcker C; Zhang IW; Kiesler S; Kassner U; Ostermann AI; Steinhagen-Thiessen E; Schebb NH; Weylandt KH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316682
[TBL] [Abstract][Full Text] [Related]
23. Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT).
Rolland Y; Barreto PS; Maltais M; Guyonnet S; Cantet C; Andrieu S; Vellas B
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426362
[TBL] [Abstract][Full Text] [Related]
24. Genetic profiling of fatty acid desaturase polymorphisms identifies patients who may benefit from high-dose omega-3 fatty acids in cardiac remodeling after acute myocardial infarction-Post-hoc analysis from the OMEGA-REMODEL randomized controlled trial.
Kwong RY; Heydari B; Ge Y; Abdullah S; Fujikura K; Kaneko K; Harris WS; Jerosch-Herold M; Antman EM; Seidman JG; Pfeffer MA
PLoS One; 2019; 14(9):e0222061. PubMed ID: 31532795
[TBL] [Abstract][Full Text] [Related]
25. Impact of Different Doses of Omega-3 Fatty Acids on Cardiovascular Outcomes: a Pairwise and Network Meta-analysis.
Lombardi M; Chiabrando JG; Vescovo GM; Bressi E; Del Buono MG; Carbone S; Koenig RA; Van Tassell BW; Abbate A; Biondi-Zoccai G; Dixon DL
Curr Atheroscler Rep; 2020 Jul; 22(9):45. PubMed ID: 32671519
[TBL] [Abstract][Full Text] [Related]
26. Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial.
Heydari B; Abdullah S; Pottala JV; Shah R; Abbasi S; Mandry D; Francis SA; Lumish H; Ghoshhajra BB; Hoffmann U; Appelbaum E; Feng JH; Blankstein R; Steigner M; McConnell JP; Harris W; Antman EM; Jerosch-Herold M; Kwong RY
Circulation; 2016 Aug; 134(5):378-91. PubMed ID: 27482002
[TBL] [Abstract][Full Text] [Related]
27. Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction.
Patel JV; Lee KW; Tomson J; Dubb K; Hughes EA; Lip GY
Int J Cardiol; 2007 Jan; 115(1):42-5. PubMed ID: 16781788
[TBL] [Abstract][Full Text] [Related]
28. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
Marchioli R; Barzi F; Bomba E; Chieffo C; Di Gregorio D; Di Mascio R; Franzosi MG; Geraci E; Levantesi G; Maggioni AP; Mantini L; Marfisi RM; Mastrogiuseppe G; Mininni N; Nicolosi GL; Santini M; Schweiger C; Tavazzi L; Tognoni G; Tucci C; Valagussa F;
Circulation; 2002 Apr; 105(16):1897-903. PubMed ID: 11997274
[TBL] [Abstract][Full Text] [Related]
29. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
30. Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors.
Dawczynski C; Massey KA; Ness C; Kiehntopf M; Stepanow S; Platzer M; Grün M; Nicolaou A; Jahreis G
Clin Nutr; 2013 Oct; 32(5):686-96. PubMed ID: 23332800
[TBL] [Abstract][Full Text] [Related]
31. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial.
Mayser P; Mrowietz U; Arenberger P; Bartak P; Buchvald J; Christophers E; Jablonska S; Salmhofer W; Schill WB; Krämer HJ; Schlotzer E; Mayer K; Seeger W; Grimminger F
J Am Acad Dermatol; 1998 Apr; 38(4):539-47. PubMed ID: 9555791
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
Schunck WH; Konkel A; Fischer R; Weylandt KH
Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
[TBL] [Abstract][Full Text] [Related]
33. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
Saravanan P; Bridgewater B; West AL; O'Neill SC; Calder PC; Davidson NC
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):46-53. PubMed ID: 20042769
[TBL] [Abstract][Full Text] [Related]
34. Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis.
Costanzo S; di Niro V; Di Castelnuovo A; Gianfagna F; Donati MB; de Gaetano G; Iacoviello L
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):906-11. PubMed ID: 23587470
[TBL] [Abstract][Full Text] [Related]
35. Effects of omega-3 fatty acid supplementation on the pattern of oxylipins: a short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids.
Ostermann AI; Schebb NH
Food Funct; 2017 Jul; 8(7):2355-2367. PubMed ID: 28682409
[TBL] [Abstract][Full Text] [Related]
36. Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on Major Eicosanoids: A Systematic Review and Meta-Analysis from 18 Randomized Controlled Trials.
Jiang J; Li K; Wang F; Yang B; Fu Y; Zheng J; Li D
PLoS One; 2016; 11(1):e0147351. PubMed ID: 26808318
[TBL] [Abstract][Full Text] [Related]
37. Preoperative carbohydrate load and intraoperatively infused omega-3 polyunsaturated fatty acids positively impact nosocomial morbidity after coronary artery bypass grafting: a double-blind controlled randomized trial.
Feguri GR; de Lima PRL; de Cerqueira Borges D; Toledo LR; Batista LN; E Silva TC; Segri NJ; de Aguilar-Nascimento JE
Nutr J; 2017 Apr; 16(1):24. PubMed ID: 28427403
[TBL] [Abstract][Full Text] [Related]
38. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
Macchia A; Grancelli H; Varini S; Nul D; Laffaye N; Mariani J; Ferrante D; Badra R; Figal J; Ramos S; Tognoni G; Doval HC;
J Am Coll Cardiol; 2013 Jan; 61(4):463-468. PubMed ID: 23265344
[TBL] [Abstract][Full Text] [Related]
39. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
[TBL] [Abstract][Full Text] [Related]
40. Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD).
Siniarski A; Haberka M; Mostowik M; Gołębiowska-Wiatrak R; Poręba M; Malinowski KP; Gąsior Z; Konduracka E; Nessler J; Gajos G
Atherosclerosis; 2018 Apr; 271():148-155. PubMed ID: 29518747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
